Restricted accessResearch articleFirst published online 2024-01
Concomitant Resistance to Cefiderocol and Ceftazidime/Avibactam in Two Carbapenemase-Producing Klebsiella pneumoniae Isolates from Two Lung Transplant Patients
In this study, we present two cases of Klebsiella pneumoniae, one KPC-33- and one NDM-1-producing, showing resistance to cefiderocol and ceftazidime/avibactam, collected in the intensive care unit of a hospital in Northern Italy from two patients who had recently undergone lung transplantation. Whole-genome sequencing was performed to investigate the molecular features of these strains.
Get full access to this article
View all access options for this article.
References
1.
SatoT, YamawakiK. Cefiderocol: Discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin. Clin Infect Dis, 2019; 69(Suppl 7):S538–S543; doi: 10.1093/cid/ciz826
2.
HobsonCA, CointeA, JacquierH, et al.Cross-resistance to cefiderocol and ceftazidime-avibactam in KPC β-lactamase mutants and the inoculum effect. Clin Microbiol Infect, 2021; 27(8):1172.e7–e1172.e10; doi: 10.1016/j.cmi.2021.04.016
3.
KleinS, BoutinS, KocerK, et al.Rapid development of cefiderocol resistance in carbapenem-resistant Enterobacter cloacae during therapy is associated with heterogeneous mutations in the catecholate siderophore receptor cirA. Clin Infect Dis, 2022; 74(5):905–908; doi: 10.1093/cid/ciab511
4.
NurjadiD, KocerK, ChanthalangsyQ, et al.New Delhi metallo-beta-lactamase facilitates the emergence of cefiderocol resistance in Enterobacter cloacae. Antimicrob Agents Chemother, 2022; 66(2):e0201121; doi: 10.1128/AAC.02011-21
5.
TiseoG, FalconeM, LeonildiA, et al.Meropenem-vaborbactam as salvage therapy for ceftazidime-avibactam-, cefiderocol-resistant ST-512 Klebsiella pneumoniae-producing KPC-31, a D179Y variant of KPC-3. Open Forum Infect Dis, 2021; 8(6):ofab141; doi: 10.1093/ofid/ofab141
6.
YaoJ, WangJ, ChenM, et al.Cefiderocol: An overview of its in-vitro and in-vivo activity and underlying resistant mechanisms. Front Med (Lausanne), 2021; 8:741940; doi: 10.3389/fmed.2021.741940
7.
LiaoQ, DengJ, FengY, et al.Emergence of ceftazidime-avibactam resistance due to a novel blaKPC-2 mutation during treatment of carbapenem-resistant Klebsiella pneumoniae infections. J Infect Public Health. 2022May; 15(5):545–549. doi: 10.1016/j.jiph.2022.04.002.
8.
SharmaR, ParkTE, MoyS. Ceftazidime-avibactam: A novel cephalosporin/β-lactamase inhibitor combination for the treatment of resistant Gram-negative organisms. Clin Ther, 2016; 38(3):431–444; doi: 10.1016/j.clinthera.2016.01.018
9.
De CosterW, D'HertS, SchultzDT, et al.NanoPack: Visualizing and processing long-read sequencing data. Bioinformatics, 2018; 34(15):2666–2669; doi: 10.1093/bioinformatics/bty149
10.
WickRR, JuddLM, GorrieCL, et al.Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol, 2017; 13(6):e1005595; doi: 10.1371/journal.pcbi.1005595
11.
WickRR, SchultzMB, ZobelJ, et al.Bandage: Interactive visualization of de novo genome assemblies. Bioinformatics, 2015; 31(20):3350–3352; doi: 10.1093/bioinformatics/btv383
12.
SchmartzGP, HartungA, HirschP, et al.PLSDB: Advancing a comprehensive database of bacterial plasmids. Nucleic Acids Res, 2022; 50(D1):D273–D278; doi: 10.1093/nar/gkab1111
13.
LamMMC, WickRR, WattsSC, et al.A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Nat Commun, 2021; 12(1):4188; doi: 10.1038/s41467-021-24448-3
14.
AlcockBP, RaphenyaAR, LauTTY, et al.CARD 2020: Antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res, 2020; 48(D1):D517–D525; doi: 10.1093/nar/gkz935
15.
CarattoliA, ZankariE, García-FernándezA, et al.In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother, 2014; 58(7):3895–3903; doi: 10.1128/AAC.02412-14
16.
ChenL, ZhengD, LiuB, et al.VFDB 2016: Hierarchical and refined dataset for big data analysis—10 years on. Nucleic Acids Res, 2016; 44(D1):D694–D697; doi: 10.1093/nar/gkv1239
17.
DurrantMG, LiMM, SiranosianBA, et al.A bioinformatic analysis of integrative mobile genetic elements highlights their role in bacterial adaptation. Cell Host Microbe, 2020; 27(1):140–153.e9; doi: 10.1016/j.chom.2019.10.022. Erratum in: Cell Host Microbe 2020;28(5):767.
MartinMJ, CoreyBW, SannioF, et al.Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy. Proc Natl Acad Sci U S A, 2021; 118(48):e2110227118; doi: 10.1073/pnas.2110227118
20.
KarakonstantisS, RousakiM, KritsotakisEI. Cefiderocol: Systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance. Antibiotics, 2022; 11(6):723; doi: 10.3390/antibiotics11060723
21.
Delgado-ValverdeM, ConejoMDC, SerranoL, et al.Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J Antimicrob Chemother, 2020; 75(7):1840–1849; doi: 10.1093/jac/dkaa117
